RHI Magnesita's H2 2025 EBITA margin surges to 12.7% on cost actions, defying challenging market conditions.
This article covers information on RHI Magnesita N.V..
LON:RHIMRHI Magnesita has delivered the step-up it promised for the second half of 2025. Over July to October, Adjusted EBITA hit €136 million with a 12.7% margin, a notable lift from the first half’s €141 million at an 8.4% margin. That improvement arrived despite the usual summer slowdown in Q3 across northern hemisphere markets.
Adjusted EBITA is a profitability measure before interest, tax and amortisation, adjusted for one-offs. A margin is simply the percentage of sales that turns into profit. The key takeaway here is that margins have expanded meaningfully, and management is clear that most of that improvement is down to self-help – cost reductions, footprint actions, and synergies – rather than a booming end-market.
| Metric | Figure | Period / Context |
|---|---|---|
| Adjusted EBITA | €136 million | Jul-Oct 2025 |
| Adjusted EBITA margin | 12.7% | Jul-Oct 2025 |
| Adjusted EBITA | €141 million | H1 2025 |
| Adjusted EBITA margin | 8.4% | H1 2025 |
| FY 2025 Adjusted EBITA guidance | €370-390 million | Reiterated |
| Industrial order volumes | ~40% below | Versus recent years |
| Backward integration margin | 1.1% | Year-to-date |
| US local production | 65% in 2025 | Target >75% in H2 2026 |
| Year-end leverage target | ~3.0x | Following Q4 de-leveraging |
Steel volumes remain subdued and broadly in line with full-year expectations. Western automotive steel demand is particularly weak. The growth bright spots are India and META (Middle East, Africa and Türkiye), where the Group regained market share in India as planned. Europe continues to contract.
This is not a demand-driven recovery. Management is candid that end-markets, especially steel, are at a cyclical low and a rapid normalisation is not expected. The fact that margins have expanded anyway underscores the impact of the company’s cost actions.
The industrial project order book has strengthened through recent months, aligning with the H1 guidance and giving visibility for the rest of 2025. However, high-margin projects are still at a low point, with order volumes around 40% below recent years. There is also a second-half skew driven by seasonality and customer timing.
In plain terms, the pipeline is healing, not healthy. The good news is that management expects the improved H2 performance to carry into H1 2026, with modest pricing gains sticking.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
37 viewsLikes
No ratings yet
Pricing remains fiercely competitive, particularly in markets with excess supply such as China and in regions that import heavily from Chinese producers, including India, East Asia and the Middle East. Even so, RHI Magnesita achieved small price increases, helped by local-for-local supply, 4PRO contracts and its innovation pipeline.
Local-for-local means producing close to the end customer, which helps service reliability and cuts logistics risk. 4PRO contracts are performance-oriented solutions that tie refractory supply more closely to customer outcomes – useful when spot pricing is under pressure.
The self-help programme is doing the heavy lifting. SG&A savings and fixed cost reductions from two plant closures in Germany are progressing in line with guidance and account for the vast majority of the margin improvement. Integration of the former Resco plants is also on track, with synergies delivered as expected.
In North America, US local production has increased from 50% to 65% in 2025 and is expected to exceed 75% in H2 2026, reducing tariff exposure. New headwinds have emerged, though, with tariffs on raw materials and finished goods exported from Brazil to the US.
Backward integration – owning raw material mines and plants – is earning very little right now, with a 1.1% margin year-to-date due to very low raw material prices. Management is moving on further cost reduction and portfolio optimisation in these operations, aiming for a stepwise improvement over the next two years.
For investors, this is a clear optionality lever. If raw materials pricing normalises or the cost actions land, the integrated model should contribute more to Group profits than it does today.
Working capital rose temporarily to support delivery of a stronger Q4 order book and seasonal cement demand. Management expects Q4 deliveries to drive de-leveraging to approximately 3.0x by year-end. Leverage here refers to a debt-to-earnings measure; the precise definition is not disclosed.
Net debt and cash figures are not disclosed in this update, but the message is clear: inventories and receivables went up to fulfil Q4, and cash generation in the final quarter should bring leverage down.
Full-year Adjusted EBITA guidance of €370-390 million is reiterated, supported by market share recovery in India and META, cost reduction and a seasonal recovery in China. A weak US Dollar and Indian Rupee are a drag on reported results. The current industrial order book supports the view that H2’s improved performance will continue into H1 2026, with modest pricing benefits retained.
The caution flag is still up on demand. Management does not expect a quick rebound in the steel cycle, which means continued reliance on execution, mix and cost control to defend margins.
Two policy developments to note:
RHI Magnesita has strong positions and a local footprint in both regions. If implemented, these measures could turn into a tailwind in late 2026 or 2027.
This is a solid trading update in a tough market. The 12.7% margin over July-October, achieved in a seasonally softer period, shows the self-help plan is working. Cost-out, plant closures and Resco synergies are doing exactly what they should. Guidance is intact, and leverage is set to improve into year-end.
On the flip side, demand is still weak in core steel markets, backward integration profits are thin, and competitive pressure from China keeps pricing tight. Currency translation is also unhelpful. In other words, RHI Magnesita’s gains are mostly self-generated rather than cyclical – which is positive for execution quality but puts a ceiling on upside until end-markets recover.
Overall, I see a business tightening the screws, protecting profitability and positioning for operating leverage when steel and industrial demand finally turn. The execution bar remains high, but momentum is clearly better in H2 and set to carry into H1 2026.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.